Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Ning Wang, Minnan Chen, Ting Wang
Journal of Controlled Release (2019) Vol. 303, pp. 130-150
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Chitosan Derivatives and Their Application in Biomedicine
Wenqian Wang, Qiuyu Meng, Qi Li, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 487-487
Open Access | Times Cited: 771
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives
Peng Liu, Guiliang Chen, Jingchen Zhang
Molecules (2022) Vol. 27, Iss. 4, pp. 1372-1372
Open Access | Times Cited: 741
The role of liposomes in clinical nanomedicine development. What now? Now what?
Daan J.A. Crommelin, Peter van Hoogevest, Gert Storm
Journal of Controlled Release (2019) Vol. 318, pp. 256-263
Open Access | Times Cited: 292
A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents
Veera Venkata Satya Naga Lakshmi Andra, S.V.N. Pammi, Lakshmi Venkata Krishna Priya Bhatraju, et al.
BioNanoScience (2022) Vol. 12, Iss. 1, pp. 274-291
Open Access | Times Cited: 179
Nanoparticles and Vaccine Development
Mehdi Kheirollahpour, Mohsen Mehrabi, Naser Mohammadpour Dounighi, et al.
Pharmaceutical Nanotechnology (2019) Vol. 8, Iss. 1, pp. 6-21
Closed Access | Times Cited: 150
Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 136
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 126
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis
Jun Chen, Xixi Zhang, R. Carl Millican, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 142-199
Open Access | Times Cited: 116
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 115
Peptide-Based Vaccines for Tuberculosis
Wenping Gong, Chao Pan, Peng Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 58
miRNAs: The Road from Bench to Bedside
Giuseppe Iacomino
Genes (2023) Vol. 14, Iss. 2, pp. 314-314
Open Access | Times Cited: 48
Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?
Iveta Klojdová, Tomáš Milota, Jitka Smetanová, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 362-362
Open Access | Times Cited: 44
Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols
Stefano Giordani, Valentina Marassi, Andrea Zattoni, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115751-115751
Open Access | Times Cited: 44
Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles
Zakia Belhadj, Yunkai Qie, Randy P. Carney, et al.
BMEMat (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 43
Immunological nanomaterials to combat cancer metastasis
Yuanbo Pan, Junjie Cheng, Yang Zhu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 12, pp. 6399-6444
Closed Access | Times Cited: 21
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate
Marcellus Korompis, Cynthia Voss, Shuailin Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Liposomes: Biomedical Applications
Eun‐Mi Kim, Hwan‐Jeong Jeong
Chonnam Medical Journal (2021) Vol. 57, Iss. 1, pp. 27-27
Open Access | Times Cited: 102
The continued advance of vaccine adjuvants – ‘we can work it out’
Derek T. O’Hagan, Rushit N. Lodaya, Giuseppe Lofano
Seminars in Immunology (2020) Vol. 50, pp. 101426-101426
Open Access | Times Cited: 101
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1549-1560
Open Access | Times Cited: 98
Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery
Alex Bunker, Tomasz Róg
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 96
Recent progress of graphene oxide as a potential vaccine carrier and adjuvant
Wanjun Cao, Lin He, Weidong Cao, et al.
Acta Biomaterialia (2020) Vol. 112, pp. 14-28
Closed Access | Times Cited: 85
Nanovaccine: an emerging strategy
Amrita Das, Nahid Ali
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1273-1290
Closed Access | Times Cited: 83
Army Liposome Formulation (ALF) family of vaccine adjuvants
Carl R. Alving, Kristina K. Peachman, Gary R. Matyas, et al.
Expert Review of Vaccines (2020) Vol. 19, Iss. 3, pp. 279-292
Open Access | Times Cited: 79
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 79
Page 1 - Next Page

Scroll to top